TCL Archive In Brief: Smyth Moves From AOR To Bristol-Myers; Lurie Center Wins Grants From Army, NCI December 13, 1996
TCL Archive ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard September 13, 2002
TCL Archive An “insurgency” targets randomized trials, demands access to investigational drugs. August 5, 2005
TCL Archive Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial December 25, 2009